招募中 NCT04689802

识别用于癌症筛查的潜在新尿液标记组合

未指定不适用

多胺是我们细胞内自然产生的代谢物。有报告显示,不同癌症患者的尿液多胺水平会出现变化。本研究旨在探讨利用尿液多胺诊断常见癌症。

适应症:Cancer

入组条件

纳入标准

  • Adult patients with age \> 18 years old.
  • For cancer patients, a histological diagnosis of cancer is available.
  • For normal control, there is no diagnosis of cancer in the medical record.

排除标准

  • Patient with recent urinary tract infection within 6 weeks prior to urine collection.
  • Patient with recent urethral instrumentation, such as Foley catheter insertion, cystoscopy etc, within 6 weeks prior to urine collection.
  • Patient refused or unable to provide consent for the study

入组条件维持 ClinicalTrials.gov 原始英文登记资料,实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源:ClinicalTrials.gov,每两周自动更新,最后同步:2026年10月8日。